Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
Frontiers | Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
Guideline Therapeutics and COVID-19: living guideline
Molecules | Free Full-Text | Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
XXXVII Congreso SETH 2021.indd
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities | Journal of Medicinal Chemistry
Guideline Therapeutics and COVID-19: living guideline
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
REVISTA ESPAÑOLA DE
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Comunicaciones orales
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances
MADS NØRGAARD – COPENHAGEN – MADS NØRGAARD - COPENHAGEN
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
